BVF as of March 31, 2016
Portfolio Holdings for BVF
BVF holds 32 positions in its portfolio as reported in the March 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Blueprint Medicines (BPMC) | 11.8 | $48M | 2.6M | 18.05 | |
| Concert Pharmaceuticals I equity | 9.3 | $38M | 2.8M | 13.66 | |
| Cytokinetics (CYTK) | 7.6 | $31M | 4.3M | 7.05 | |
| Forward Pharma A/s | 6.1 | $25M | 1.4M | 17.00 | |
| Oncothyreon | 5.9 | $24M | 19M | 1.27 | |
| Cti Biopharma | 5.9 | $24M | 45M | 0.53 | |
| Array BioPharma | 5.7 | $23M | 7.9M | 2.95 | |
| Exelixis Inc cnv | 5.7 | $23M | 23M | 1.00 | |
| Chemocentryx | 5.0 | $20M | 8.2M | 2.49 | |
| Ironwood Pharmaceuticals (IRWD) | 4.8 | $19M | 1.8M | 10.94 | |
| Vitae Pharmaceuticals | 3.4 | $14M | 2.1M | 6.63 | |
| Oncomed Pharmaceuticals | 3.4 | $14M | 1.3M | 10.11 | |
| ArQule | 3.1 | $13M | 7.9M | 1.60 | |
| Xenon Pharmaceuticals (XENE) | 3.1 | $12M | 1.8M | 6.99 | |
| Qlt | 2.8 | $11M | 5.7M | 1.99 | |
| Esperion Therapeutics (ESPR) | 2.5 | $10M | 607k | 16.91 | |
| Tobira Therapeutics Inc Common Stock Usd 0.0001 | 2.5 | $10M | 1.3M | 8.18 | |
| Celator Pharmaceuticals | 2.2 | $8.8M | 800k | 11.03 | |
| Cytomx Therapeutics (CTMX) | 1.9 | $7.8M | 606k | 12.90 | |
| Nivalis Therapeutics | 1.6 | $6.4M | 1.5M | 4.17 | |
| GTx | 1.4 | $5.8M | 12M | 0.50 | |
| Pain Therapeutics | 1.2 | $4.8M | 2.1M | 2.23 | |
| Sunesis Pharmaceuticals | 0.6 | $2.6M | 4.8M | 0.54 | |
| Loxo Oncology | 0.5 | $2.0M | 75k | 27.34 | |
| Array Biopharma Inc note 3.000% 6/0 | 0.5 | $2.0M | 2.5M | 0.81 | |
| Catalyst Biosciences | 0.4 | $1.6M | 971k | 1.68 | |
| Globeimmune (GBIM) | 0.3 | $1.4M | 658k | 2.06 | |
| Mast Therapeutics | 0.2 | $998k | 3.7M | 0.27 | |
| Calithera Biosciences | 0.2 | $925k | 163k | 5.68 | |
| Biota Pharmaceuticals | 0.1 | $526k | 351k | 1.50 | |
| Ignyta | 0.1 | $339k | 50k | 6.78 | |
| Nephrogenex | 0.1 | $184k | 392k | 0.47 |
